A new report suggests that Covid-19 has mutated into a new, strong strain; former head of the FDA Dr. Scott Gottlieb explains the relationship between virus mutations and increased infectiousness. Adaptive Biotechnologies CEO explains how his company is working on developing coronavirus treatments using human immune systems. Plus, office culture as we know it may change once the pandemic subsides. Features Director at Architectural Digest Sam Cochran discusses building a new normal in the workplace.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.